Skip to main content
. Author manuscript; available in PMC: 2014 Aug 19.
Published in final edited form as: Cornea. 2013 Jan;32(1):44–53. doi: 10.1097/ICO.0b013e318254205f

Figure 1.

Figure 1

A) Patients with MGD reported global improvement in symptoms in response to 8 weeks of oral doxycycline therapy. FBS: foreign body sensation, NS: not statistically significant (p > 0.05). Filled bars: Subjects with MGD prior to treatment. Open bars: Patients after 8 weeks of doxycycline treatment. B) Signs of MGD were improved in patients with MGD in response to 8 weeks of oral doxycycline therapy. Symptoms were assessed from a questionnaire. C) Improvement in symptoms after 8 weeks of doxycycline therapy, open bars, compared with published42 improvement in symptoms after 4 weeks topical azithromycin therapy (filled bars). D) Improvement in signs after 8 weeks of doxycycline therapy, open bars, compared with published42 improvement in signs after 4 weeks topical azithromycin therapy (filled bars). * Statistically significant difference, p < 0.05.